Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Obstet Gynecol. 2019 Dec;134(6):1205–1214. doi: 10.1097/AOG.0000000000003584

Table 2.

Cohort 1: Unadjusted and Adjusted Risk Ratios for Hypertensive Disorders of Pregnancy Outcomes Comparing Pregnancies in Antiretroviral Therapy–Exposed Pregnant Women Living With Human Immunodeficiency Virus With Those in Pregnancies in Women Without Human Immunodeficiency Virus

Outcome RR (95% CI) Adjusted RR (95% CI)
HDP* 1.0 (0.7–1.4) 0.9 (0.6–1.3)
Gestational hypertension 1.2 (0.8–1.8) 1.0 (0.7–1.6)
Preeclampsia 0.6 (0.3–1.2) 0.5 (0.3–1.2)

RR, risk ratio; HDP, hypertensive disorders of pregnancy.

All models adjusted for age, race, and tobacco and illicit drug use.

One hundred nineteen (3%) observations had missing data for a covariate and are excluded from the analysis.

*

Gestational hypertension, preeclampsia, eclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome.